OnabotulinumtoxinA vs sacral neuromodulation for urgency incontinence-Reply

Cindy L. Amundsen; Holly E. Richter; Dennis Wallace

doi:doi:10.1001/jama.2016.19566

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept

OnabotulinumtoxinA vs sacral neuromodulation for urgency incontinence-Reply

Amundsen, C. L., Richter, H. E., Wallace, D., & Pelvic Floor Disorders Network (2017). OnabotulinumtoxinA vs sacral neuromodulation for urgency incontinence-Reply. JAMA, 317(5), 535-536. https://doi.org/10.1001/jama.2016.19566

Copy citation

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults

Article

Epigenetic biomarkers for smoking cessation

Article

A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood

Article

OnabotulinumtoxinA vs sacral neuromodulation for urgency incontinence-Reply

Publications Info

Recent Publications

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults

Epigenetic biomarkers for smoking cessation

A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood

The effects of exposure to road traffic noise at school on central auditory pathway functional connectivity

Partner With Us

Site